SK Plasma wins Singapore national blood product tender for 6-year exclusive supply

SK Plasma, a subsidiary of SK Discovery, won a national tender from the Singapore government to exclusively supply blood products (albumin and human immunoglobulin) for 6 years starting 2023. The contract is valued at approximately $23 million.

“이번 성과는 품질에 대해 까다로운 눈높이를 지닌 싱가포르 당국에서 국내 기업의 기술력과 관리·생산 능력을 인정받은 첫 사례”mk.co.kr

• 1 source
• mk.co.kr[바이오] 싱가포르 국가 혈액제제 입찰…SK플라즈마, 6년간 독점공급 - 매일경제유주연 기자Nov 2, 2021

Summarized from public sources; check the original articles before acting on it.